{"id":34750,"date":"2020-05-16T12:00:00","date_gmt":"2020-05-16T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/"},"modified":"2020-05-16T12:00:00","modified_gmt":"2020-05-16T12:00:00","slug":"prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/","title":{"rendered":"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--2747 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h3><strong>Une d\u00e9claration d\u2019EUFOREA<\/strong><\/h3>\n<p>Le printemps et l\u2019\u00e9t\u00e9 2020 sont uniques en ce sens que les d\u00e9fis de la prise en charge des personnes souffrant d\u2019allergie aux pollens co\u00efncident avec la pand\u00e9mie de COVID-19. Plusieurs \u00e9l\u00e9ments doivent \u00eatre pris en compte afin de permettre une prise en charge optimale de la rhinite allergique (RA) et de l\u2019asthme, et donc de pr\u00e9venir la propagation du coronavirus par les \u00e9ternuements, la rhinorrh\u00e9e et la toux. <\/p>\n<p>Cette synth\u00e8se concise des recommandations des \u00e9quipes d\u2019experts d\u2019EUFOREA sur les maladies allergiques des voies a\u00e9riennes et l\u2019immunoth\u00e9rapie sp\u00e9cifique aux allerg\u00e8nes (AIT) repose sur une analyse de la litt\u00e9rature actuelle sur la COVID-19, en association avec les mots-cl\u00e9s ci-dessus, ainsi que sur l\u2019exp\u00e9rience clinique partag\u00e9e des experts impliqu\u00e9s. Elle traite des similitudes et des diff\u00e9rences entre la RA et l\u2019infection \u00e0 coronavirus, des recommandations sp\u00e9cifiques pour la prise en charge des maladies allergiques \u00e0 l\u2019\u00e8re de la COVID-19, y compris des orientations sur l\u2019AIT. <\/p>\n<p><strong>Co-auteurs :<\/strong> Glenis Scaddings, Peter Hellings, Claus Bachertc, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann et Ulrich Wahn.<\/p>\n<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120300272\" target=\"_blank\" rel=\"noopener\"><strong>Lire la d\u00e9claration ici<\/strong><\/a><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph photo-gallery paragraph-id--2750 paragraph--type--photo-gallery paragraph--view-mode--default clearfix p-photo-gallery--col\">\n<div class=\"photo-gallery__content\">\n<div class=\"paragraph photo paragraph-id--2748 paragraph--type--photo paragraph--view-mode--default clearfix\"><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Fig.20120Similarities20and20differences20between20seasonal20allergic20rhinitis20and20COVID-201920symptoms1.png\" data-caption=\"Fig 2. Treatment algorithm for AR as proposed by EUFOREA, taking into account the reality of patient phenotypes and existing international guidelines. www.euforea.org. Treatments suggested are possible during the COVID-19 pandemic with the exception of the use of systemic corticosteroids which should be avoided as they may be immunosuppressive. The symbol '>&#8216; means &#8216;more than.'&#8221; data-fancybox=&#8221;images&#8221;><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Fig.-1-Similarities-and-differences-between-seasonal-allergic-rhinitis-and-COVID-19-symptoms.png\" alt=\"Algorithme de la rhinite allergique\"><br \/>\n<\/a><\/div>\n<div class=\"paragraph photo paragraph-id--2749 paragraph--type--photo paragraph--view-mode--default clearfix\"><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergic20Rhinitis20Algorithm1.png\" data-caption=\"Fig 1. Similarities and differences between seasonal allergic rhinitis and COVID-19 symptoms.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergic-Rhinitis-Algorithm.png\" alt=\"Similitudes et diff\u00e9rences entre les sympt\u00f4mes de la rhinite allergique saisonni\u00e8re et ceux de la COVID-19\"><br \/>\n<\/a><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Une d\u00e9claration d\u2019EUFOREA Le printemps et l\u2019\u00e9t\u00e9 2020 sont uniques en ce sens que les d\u00e9fis de la prise en charge des personnes souffrant d\u2019allergie aux pollens co\u00efncident avec la pand\u00e9mie de COVID-19. Plusieurs \u00e9l\u00e9ments doivent \u00eatre pris en compte afin de permettre une prise en charge optimale de la rhinite allergique (RA) et de l\u2019asthme, et donc de pr\u00e9venir la propagation du coronavirus par les \u00e9ternuements, la rhinorrh\u00e9e et la toux. Cette synth\u00e8se concise des recommandations des \u00e9quipes d\u2019experts d\u2019EUFOREA sur les maladies allergiques des voies a\u00e9riennes et l\u2019immunoth\u00e9rapie sp\u00e9cifique aux allerg\u00e8nes (AIT) repose sur une analyse de la litt\u00e9rature actuelle sur la COVID-19, en association avec les mots-cl\u00e9s ci-dessus, ainsi que sur l\u2019exp\u00e9rience clinique partag\u00e9e des experts impliqu\u00e9s. Elle traite des similitudes et des diff\u00e9rences entre la RA et l\u2019infection \u00e0 coronavirus, des recommandations sp\u00e9cifiques pour la prise en charge des maladies allergiques \u00e0 l\u2019\u00e8re de la COVID-19, y compris des orientations sur l\u2019AIT. Co-auteurs : Glenis Scaddings, Peter Hellings, Claus Bachertc, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann et Ulrich Wahn. Lire la d\u00e9claration ici<\/p>\n","protected":false},"author":1,"featured_media":34762,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[266],"tags":[195,269,284],"class_list":["post-34750","news","type-news","status-publish","has-post-thumbnail","hentry","category-publications","tag-maladies-respiratoires-chroniques-mrc","tag-rhinite-allergique-ra","tag-publications"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19\" \/>\n<meta property=\"og:description\" content=\"Une d\u00e9claration d\u2019EUFOREA Le printemps et l\u2019\u00e9t\u00e9 2020 sont uniques en ce sens que les d\u00e9fis de la prise en charge des personnes souffrant d\u2019allergie aux pollens co\u00efncident avec la pand\u00e9mie de COVID-19. Plusieurs \u00e9l\u00e9ments doivent \u00eatre pris en compte afin de permettre une prise en charge optimale de la rhinite allergique (RA) et de l\u2019asthme, et donc de pr\u00e9venir la propagation du coronavirus par les \u00e9ternuements, la rhinorrh\u00e9e et la toux. Cette synth\u00e8se concise des recommandations des \u00e9quipes d\u2019experts d\u2019EUFOREA sur les maladies allergiques des voies a\u00e9riennes et l\u2019immunoth\u00e9rapie sp\u00e9cifique aux allerg\u00e8nes (AIT) repose sur une analyse de la litt\u00e9rature actuelle sur la COVID-19, en association avec les mots-cl\u00e9s ci-dessus, ainsi que sur l\u2019exp\u00e9rience clinique partag\u00e9e des experts impliqu\u00e9s. Elle traite des similitudes et des diff\u00e9rences entre la RA et l\u2019infection \u00e0 coronavirus, des recommandations sp\u00e9cifiques pour la prise en charge des maladies allergiques \u00e0 l\u2019\u00e8re de la COVID-19, y compris des orientations sur l\u2019AIT. Co-auteurs : Glenis Scaddings, Peter Hellings, Claus Bachertc, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann et Ulrich Wahn. Lire la d\u00e9claration ici\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Fig.-1-Similarities-and-differences-between-seasonal-allergic-rhinitis-and-COVID-19-symptoms.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/\",\"name\":\"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergic20Respiratory20Disease20Care20in20the20COVID-1920Era20Teaser.png\",\"datePublished\":\"2020-05-16T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergic20Respiratory20Disease20Care20in20the20COVID-1920Era20Teaser.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergic20Respiratory20Disease20Care20in20the20COVID-1920Era20Teaser.png\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/","og_locale":"fr_FR","og_type":"article","og_title":"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19","og_description":"Une d\u00e9claration d\u2019EUFOREA Le printemps et l\u2019\u00e9t\u00e9 2020 sont uniques en ce sens que les d\u00e9fis de la prise en charge des personnes souffrant d\u2019allergie aux pollens co\u00efncident avec la pand\u00e9mie de COVID-19. Plusieurs \u00e9l\u00e9ments doivent \u00eatre pris en compte afin de permettre une prise en charge optimale de la rhinite allergique (RA) et de l\u2019asthme, et donc de pr\u00e9venir la propagation du coronavirus par les \u00e9ternuements, la rhinorrh\u00e9e et la toux. Cette synth\u00e8se concise des recommandations des \u00e9quipes d\u2019experts d\u2019EUFOREA sur les maladies allergiques des voies a\u00e9riennes et l\u2019immunoth\u00e9rapie sp\u00e9cifique aux allerg\u00e8nes (AIT) repose sur une analyse de la litt\u00e9rature actuelle sur la COVID-19, en association avec les mots-cl\u00e9s ci-dessus, ainsi que sur l\u2019exp\u00e9rience clinique partag\u00e9e des experts impliqu\u00e9s. Elle traite des similitudes et des diff\u00e9rences entre la RA et l\u2019infection \u00e0 coronavirus, des recommandations sp\u00e9cifiques pour la prise en charge des maladies allergiques \u00e0 l\u2019\u00e8re de la COVID-19, y compris des orientations sur l\u2019AIT. Co-auteurs : Glenis Scaddings, Peter Hellings, Claus Bachertc, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann et Ulrich Wahn. Lire la d\u00e9claration ici","og_url":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Fig.-1-Similarities-and-differences-between-seasonal-allergic-rhinitis-and-COVID-19-symptoms.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/","url":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/","name":"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergic20Respiratory20Disease20Care20in20the20COVID-1920Era20Teaser.png","datePublished":"2020-05-16T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergic20Respiratory20Disease20Care20in20the20COVID-1920Era20Teaser.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergic20Respiratory20Disease20Care20in20the20COVID-1920Era20Teaser.png","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/prise-en-charge-des-maladies-respiratoires-allergiques-a-lere-de-la-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Prise en charge des maladies respiratoires allergiques \u00e0 l\u2019\u00e8re de la COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=34750"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34750\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/34762"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=34750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=34750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=34750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}